Resistant Pathogen Trial News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Resistant Pathogen Trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Resistant Pathogen Trial Today - Breaking & Trending Today

ContraFect Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Published: August 15, 2022

YONKERS, N.Y., Aug. 15, 2022 -- ContraFect Corporation , a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents , including lysins and amurin... | August 15, 2022

Source: marketscreener.com

Related Topics:

Cara CassinoGarrett NicholsMichael MessingerRogerj PomerantzEuropean CongressContrafect CorporationExchange CommissionContrafect Corporation NasdaqUniversity Of WashingtonCompany Quarterly Report On FormDuke UniversityDevelopment Of The CompanyGlobenewswire IncFect CorporationChief Executive OfficerData Safety Monitoring BoardDirect LysisResistant Pathogen TrialChief Medical OfficerExecutive Vice PresidentInterim Chief MedicalClinical MicrobiologyInfectious DiseasesAnnual MeetingEscherichia Coli

ContraFect Reports Second Quarter 2022 Financial Results

Published: August 15, 2022

Focused on advancement of lead programs, exebacase and CF-370, into new clinical studies...

Source: globenewswire.com

Related Topics:

Cara CassinoGarrett NicholsRogerj PomerantzExchange CommissionContrafect Corporation NasdaqEuropean CongressUniversity Of WashingtonDuke UniversityDevelopment Of The CompanyFect CorporationChief Executive OfficerData Safety Monitoring BoardDirect LysisResistant Pathogen TrialChief Medical OfficerExecutive Vice PresidentInterim Chief MedicalClinical MicrobiologyInfectious DiseasesAnnual MeetingEscherichia ColiBreakthrough TherapyNasdaq CfrxContrafect Corporation